Genomic Biopharma and patient advocacy organization POIC e dintorni APS partner to offer whole genome sequencing to bring better treatments and cures to those living with gastrointestinal diseases
L’AQUILA, Italy, Dec. 12, 2022 (GLOBE NEWSWIRE) — Genomic Biopharma Inc., a genomic medicine-based drug discovery and development company, has partnered with Associazione Poic e Dintorni APS (“POIC e dintorni APS”), a patient organization that supports the advocacy of chronic intestinal pseudo-obstruction (CIPO), to enable access to whole genome sequencing (WGS) and demonstrate the utility […]
Read More